Pharmaceuticals Industry

A key emerging EU requirement is the recast Urban Wastewater Treatment Directive (EU) 2024/3019. By 31 December 2028, Member States must establish extended producer responsibility for producers placing specified pharmaceutical and cosmetic products on the market, with producers covering at least 80% of relevant costs for quaternary treatment and micropollutant monitoring, subject to the Directive's exemptions and national implementation. PPWR also affects primary, secondary and transport packaging used for medicines as its phased requirements apply. In parallel, the EU pharmaceutical reform reached political agreement in December 2025 and includes an objective to make medicines more environmentally sustainable; final obligations should be monitored as the legal texts are formally implemented.

For companies, the operational priorities include energy and carbon reduction, water efficiency, solvent and chemical management, wastewater quality, product and packaging footprints, cold-chain emissions and supplier transparency. Environmental risk should be assessed without creating simplistic conclusions: a lower-carbon formulation or pack must still meet quality, stability and patient-safety requirements. Product-level LCA can help quantify these trade-offs and identify hotspots across active ingredients, excipients, manufacturing, packaging and distribution.

Metsims can support pharmaceutical companies with corporate carbon accounting, Scope 3 analysis, product and packaging LCA, Product Carbon Footprint, water footprinting, wastewater-related environmental assessment and decarbonisation planning. Packaging studies can evaluate PPWR-related redesign options, while supplier engagement can improve emissions and environmental data for active ingredients, excipients and outsourced manufacturing.

For organisations preparing for extended producer responsibility and wider environmental requirements, Metsims can map data needs, quantify environmental hotspots and develop measurable improvement scenarios. This creates a technical evidence base for regulatory readiness, product development, procurement decisions and transparent sustainability communication without compromising the sector's quality and safety priorities.

Industrial understanding and multidisciplinary depth. Select an advisor to open their dedicated Metsims profile.